Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study.
Lingyu HuRuiting HuangFuqiong JiangShuqiong YouQian WuPublished in: Immunity, inflammation and disease (2023)
Dupilumab can effectively control the condition of bullous pemphigoid, efficiently relieve pruritus symptoms, and is relatively safe.